6505-00-890-1840 Metronidazole tablets
One item DLA buys: its open requests for quotation, approved sources and past DLA awards.
Overview
National Stock Number record
- Open RFQs
- 1
- Next due November 23, 2026
- Last price paid
- …
- Standard price
- $104.90 per BT
- DLA's catalog price, not a price paid
- Approved sources
- 2
- Awards on record
- 531
- 2013 to 2026
- DLA demand
- –
Identification
- Item name
- Metronidazole tablets
- FSC / PSC
- 6505 · Drugs and biologicals
- NSG (group)
- 65 · Medical/dental/veterinary eqpt/supp
- NIIN assigned
- 01-JAN-60
- Unit
- BT
- NSN
- 6505-00-890-1840
- NIIN
- 00-890-1840
Name, end product, NIIN date and unit: DLA's Federal Logistics Information System (PUB LOG). Source: the request-for-quotation (RFQ) files DLA publishes on DIBBS each day. An RFQ that is also a SAM.gov notice links to that notice. Return-by dates are DIBBS's.
Approved suppliers
Manufacturers and suppliers DLA has qualified for this item
| Supplier | CAGE | CAGE status | Part status (RNCC / RNVC) | Supplier part # |
|---|---|---|---|---|
| PLIVA INC. | 3PYX2 | A (Active) | 3 (Design control reference) / 2 (An item-identifying number) | NDC50111-0333-06 |
| TEVA PHARMACEUTICALS USA, INC. | 3V8D7 | A (Active) | 5 (Secondary reference) / 2 (An item-identifying number) | NDC50111-0333-06 |
Source: DLA's approved-source file published with the RFQs. CAGE and part status are FLIS's codes with DLA's wording.
Pricing and awardees
Supply contracts
4 contracts DLA ordered this item under
| Award ID | Awardee | Awarding office | Ceiling | Ordering ends | Type | Multiple award | Orders | Last order |
|---|---|---|---|---|---|---|---|---|
| SPE2DX25D8022 | CARDINAL HEALTH, INC. | SPE2DX | $76,117,432 | March 6, 2035 | INDEFINITE DELIVERY / REQUIREMENTS | No | 7 | October 8, 2026 |
| SPE2DX25D9900 | DMS PHARMACEUTICAL GROUP INC | SPE2DX | $19,999,999 | March 6, 2038 | INDEFINITE DELIVERY / REQUIREMENTS | No | 13 | July 24, 2026 |
| SPE2DX15D0022 | CARDINAL HEALTH, INC. | SPE2DX | $20,000,000 | June 30, 2025 | INDEFINITE DELIVERY / INDEFINITE QUANTITY | No | 58 | December 20, 2018 |
| SPE2DX15D9383 | DMS PHARMACEUTICAL GROUP INC | SPE2DX | $4,999,999 | December 31, 2025 | INDEFINITE DELIVERY / INDEFINITE QUANTITY | No | 1 | April 10, 2018 |
Source: DLA's procurement history files (the contract each order was placed under), the item's newest 2,000 award lines, joined to FPDS by the contract number. Multiple award, ordering period and ceiling are FPDS's; DLA's files do not give them.
Characteristics
Government-defined characteristics of this item (FLIS)
Hazardous and environmental
- Hazardous material (HMIC)
- Y (In hmirs)
Additional identifiers
- II
- 0
- DEMIL
- A: No demilitarization required
- Precious metals (PMIC)
- A (Does not contain precious metal)
- Schedule B
- 3004909210 (Antiprotozoals, in doses/packagd for retail, nesoi)
- PINC
- 0030969
- Criticality (CRIT CD)
- X
Source: DLA's PUB LOG files (FLIS Data Electronic Reading Room), updated monthly; code wording from DLA's code table (P_HELP).
Major organizational entity (MOE) rules
How each service or agency buys and manages this item
| Rule | MOE | AMC | AMSC | NIMSC | IMC | AAC | DSOR |
|---|---|---|---|---|---|---|---|
| A911 | Army (DA) | 3From the actual manufacturer (second or later time) | ZCommercial or off-the-shelf item | ||||
| C922 | U.S. coast guard (GP) | 3From the actual manufacturer (second or later time) | ZCommercial or off-the-shelf item | ||||
| FSGM | Air Force (DF) | 3From the actual manufacturer (second or later time) | ZCommercial or off-the-shelf item | ||||
| MC55 | Marine Corps (DM) | 3From the actual manufacturer (second or later time) | ZCommercial or off-the-shelf item | ||||
| N9BL | Navy (DN) | 3From the actual manufacturer (second or later time) | ZCommercial or off-the-shelf item | ||||
| ZH01 | Republic of korea (ZH) | ||||||
| ZW01 | Turkey (ZW) |
Source: DLA's PUB LOG files (FLIS Data Electronic Reading Room), updated monthly; code wording from DLA's code table (P_HELP). AMC and AMSC wording: DFARS PGI 217.7506. Hover a code for DLA's wording.
Government organizations
The services and agencies that manage or use this item
| Organization | Effective date | Unit of issue | Unit price | Qty per unit | Controlled inventory | Shelf life | Acquisition advice | Source of supply |
|---|---|---|---|---|---|---|---|---|
| Army (DA) | 01-OCT-2025 | BT | $79.73 | 1 (1) | U (Unclassified) | M (24 months) | L (Local purchase) | SMS (Defense logistics agency) |
| Air Force (DF) | 01-OCT-2025 | BT | $79.73 | 1 (1) | U (Unclassified) | M (24 months) | L (Local purchase) | SMS (Defense logistics agency) |
| Marine Corps (DM) | 01-OCT-2025 | BT | $79.73 | 1 (1) | U (Unclassified) | M (24 months) | L (Local purchase) | SMS (Defense logistics agency) |
| Navy (DN) | 01-OCT-2025 | BT | $79.73 | 1 (1) | U (Unclassified) | M (24 months) | L (Local purchase) | SMS (Defense logistics agency) |
| DLA (DS) | 01-OCT-2026 | BT | $104.90 | 1 (1) | U (Unclassified) | M (24 months) | L (Local purchase) | SMS (Defense logistics agency) |
| U.S. coast guard (GP) | 01-OCT-2025 | BT | $79.73 | 1 (1) | U (Unclassified) | M (24 months) | L (Local purchase) | SMS (Defense logistics agency) |
Source: DLA's PUB LOG files (FLIS Data Electronic Reading Room), updated monthly; code wording from DLA's code table (P_HELP). Unit prices are DLA's standard prices (its catalog price to its customers, with DLA's surcharge), not prices DLA paid.
DIBBS RFQs
Recent DLA requests for quotation for this item on DIBBS, newest first: 1 open now
| Solicitation | NSN | Item name | Qty | Unit | Std. price | Last price | Est. value | Set-aside | Tech docs | Posted | Return by |
|---|---|---|---|---|---|---|---|---|---|---|---|
| SPE2DP27T0377DIBBS only | 6505-00-890-1840 | Metronidazole tablets | 30 | BT | $104.90 per BT | … | … | No set-aside | Yes | November 15, 2026 | November 23, 20267 days left |
→ These RFQs in the DIBBS list
Source: the request-for-quotation (RFQ) files DLA publishes on DIBBS each day. An RFQ that is also a SAM.gov notice links to that notice. Return-by dates are DIBBS's.
DLA forecast
DLA's purchase forecast for the next 24 months, and its lead time
DLA's own figures
- Lead time
- administrative 15 days, production 120 days (135 in all)
Source: DLA's monthly files in its FOIA reading room: the 24-month demand forecast (what DLA expects to buy, not a commitment) and the ALT/PLT file (administrative lead time: requirement to award; production lead time: award to delivery).
DLA award history
531 award lines since 2013, 4 winning CAGEs
| Winner | Awards | Last award |
|---|---|---|
| 00E55Cardinal Health, Inc. | 479 | October 8, 2026 |
| 1UNB0DMS PHARMACEUTICAL GROUP INC | 37 | July 24, 2026 |
| 1XUY5AMERISOURCEBERGEN DRUG CORP | 12 | May 28, 2013 |
| 3W8H0MR UNLIMITED, LLC | 3 | July 10, 2025 |
| Year | Awards | Winning CAGEs |
|---|---|---|
| 2026 | 20 | 2 |
| 2025 | 24 | 3 |
| 2024 | 21 | 2 |
| 2023 | 40 | 1 |
| 2022 | 21 | 1 |
| 2021 | 42 | 1 |
| 2020 | 46 | 1 |
| 2019 | 30 | 1 |
| 2018 | 59 | 2 |
| 2017 | 40 | 2 |
| 2016 | 20 | 2 |
| 2015 | 30 | 1 |
| 2014 | 96 | 2 |
| 2013 | 42 | 3 |
Source: DLA's award history files (its FOIA reading room: every DLA award line since 2013, refreshed monthly), plus the past awards listed in this item's RFQ documents that those files lack. Counts are award lines, not dollars; surplus buys are left out.
DLA awards for this item
25 awards from the item's award history, in FPDS
| Rank | Vendor | Obligated | |
|---|---|---|---|
| 1 | CARDINAL HEALTH, INC. | $21,950 | 266 |
| 2 | DMS PHARMACEUTICAL GROUP INC | $5,031 | 27 |
| 3 | MR UNLIMITED, LLC | $660 | 3 |
| Contract | Awarded | Awardee | Obligated |
|---|---|---|---|
| SPE2D926F7996From the item's award history | August 7, 2026 | CARDINAL HEALTH, INC. | $165 |
| SPE2DP26F8255From the item's award history | July 24, 2026 | DMS PHARMACEUTICAL GROUP INC | $56 |
| SPE2D926F7480From the item's award history | July 21, 2026 | CARDINAL HEALTH, INC. | $55 |
| SPE2DP26F7180From the item's award history | July 8, 2026 | DMS PHARMACEUTICAL GROUP INC | $56 |
| SPE2DP26F6817From the item's award history | June 26, 2026 | DMS PHARMACEUTICAL GROUP INC | $56 |
| SPE2DP26F5875From the item's award history | May 19, 2026 | DMS PHARMACEUTICAL GROUP INC | $112 |
| SPE2DP26F5807From the item's award history | May 15, 2026 | DMS PHARMACEUTICAL GROUP INC | $168 |
| SPE2DP26F4720From the item's award history | April 16, 2026 | DMS PHARMACEUTICAL GROUP INC | $112 |
| SPE2D926F4646From the item's award history | April 13, 2026 | CARDINAL HEALTH, INC. | $55 |
| SPE2DP26F4624From the item's award history | April 13, 2026 | DMS PHARMACEUTICAL GROUP INC | $280 |
| SPE2DP26F3992From the item's award history | April 1, 2026 | DMS PHARMACEUTICAL GROUP INC | $112 |
| SPE2DP26F3947From the item's award history | March 30, 2026 | DMS PHARMACEUTICAL GROUP INC | $559 |
| SPE2DP26F3908From the item's award history | March 27, 2026 | DMS PHARMACEUTICAL GROUP INC | $447 |
| SPE2DP26F3709From the item's award history | March 23, 2026 | DMS PHARMACEUTICAL GROUP INC | $280 |
| SPE2DP26F2148From the item's award history | January 28, 2026 | DMS PHARMACEUTICAL GROUP INC | $112 |
| SPE2DP26F1927From the item's award history | January 23, 2026 | DMS PHARMACEUTICAL GROUP INC | $56 |
| SPE2D926F1795From the item's award history | January 13, 2026 | CARDINAL HEALTH, INC. | $331 |
| SPE2DP26F0523From the item's award history | October 30, 2025 | DMS PHARMACEUTICAL GROUP INC | $112 |
| SPE2DP26F0529From the item's award history | October 30, 2025 | DMS PHARMACEUTICAL GROUP INC | $112 |
| SPE2DP26F0534From the item's award history | October 30, 2025 | DMS PHARMACEUTICAL GROUP INC | $56 |
| SPE2DP26F0540From the item's award history | October 30, 2025 | DMS PHARMACEUTICAL GROUP INC | $112 |
| SPE2DP26F0554From the item's award history | October 30, 2025 | DMS PHARMACEUTICAL GROUP INC | $56 |
| SPE2DP26F0555From the item's award history | October 30, 2025 | DMS PHARMACEUTICAL GROUP INC | $112 |
| SPE2DP26F0558From the item's award history | October 30, 2025 | DMS PHARMACEUTICAL GROUP INC | $56 |
| SPE2DP26F0562From the item's award history | October 30, 2025 | DMS PHARMACEUTICAL GROUP INC | $56 |
Showing 1 to 10 of 25 results
Source: DLA award notices on SAM.gov for solicitations that included this item (DLA posts them above $25,000), and the contracts of this item's past DLA awards (DLA's award history files and the RFQs' procurement history), joined to FPDS by contract number (an order under a long-term contract by the order and its contract). Amounts are FPDS obligations; DIBBS order totals are not shown. Department of Defense actions appear in FPDS about 90 days after they are signed.